Cordis Corp.
Annapolis, MD 21401
Share:
New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System Receives HDE Approval from U.S. Food and Drug Administration MIAMI LAKES, Fla., May 9 -- Cordis Neurovascular, Inc. announced today that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System for use with...
Read More »New Device Granted Humanitarian Exemption to Treat Intracranial Aneurysms
CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System Receives HDE Approval from U.S. Food and Drug Administration MIAMI LAKES, Fla., May 9 -- Cordis Neurovascular, Inc. announced today that the U.S. Food and Drug Administration has granted Humanitarian Device Exemption (HDE) approval for the CORDIS ENTERPRISE(TM) Vascular Reconstruction Device and Delivery System for use with...
Read More »